For citations:
Saygina O.A., Sukhinina T.S., Terenicheva M.A., Stukalova O.V., Chashchin M.G., Pevsner D.V. Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. Rational Pharmacotherapy in Cardiology. 2025;21(6):529-535. (In Russ.) https://doi.org/10.20996/1819-6446-2025-3241
JATS XML
Email this article 